- Home
- SLNO vs ADUS Comparison
SLNO vs ADUS Comparison
Compare SLNO & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- ADUS
- Stock Information
- Founded
- SLNO 1999
- ADUS 1979
- Country
- SLNO United States
- ADUS United States
- Employees
- SLNO N/A
- ADUS N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ADUS Medical/Nursing Services
- Sector
- SLNO Health Care
- ADUS Health Care
- Exchange
- SLNO Nasdaq
- ADUS Nasdaq
- Market Cap
- SLNO 1.9B
- ADUS 2.2B
- IPO Year
- SLNO 2014
- ADUS 2009
- Fundamental
- Price
- SLNO $45.18
- ADUS $131.40
- Analyst Decision
- SLNO Strong Buy
- ADUS Buy
- Analyst Count
- SLNO 6
- ADUS 10
- Target Price
- SLNO $74.83
- ADUS $133.67
- AVG Volume (30 Days)
- SLNO 788.7K
- ADUS 171.7K
- Earning Date
- SLNO 11-06-2024
- ADUS 11-04-2024
- Dividend Yield
- SLNO N/A
- ADUS N/A
- EPS Growth
- SLNO N/A
- ADUS 23.71
- EPS
- SLNO N/A
- ADUS 4.37
- Revenue
- SLNO N/A
- ADUS $1,133,806,000.00
- Revenue This Year
- SLNO N/A
- ADUS $10.05
- Revenue Next Year
- SLNO N/A
- ADUS $22.66
- P/E Ratio
- SLNO N/A
- ADUS $30.10
- Revenue Growth
- SLNO N/A
- ADUS 10.15
- 52 Week Low
- SLNO $35.70
- ADUS $85.94
- 52 Week High
- SLNO $60.92
- ADUS $136.12
- Technical
- Relative Strength Index (RSI)
- SLNO 32.12
- ADUS 63.37
- Support Level
- SLNO $43.32
- ADUS $126.08
- Resistance Level
- SLNO $48.51
- ADUS $131.93
- Average True Range (ATR)
- SLNO 2.09
- ADUS 3.46
- MACD
- SLNO -0.38
- ADUS 1.23
- Stochastic Oscillator
- SLNO 20.44
- ADUS 92.04
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.